SUZUKEN : Notice Regarding Result of Acquisition of Treasury Shares by Own Share Repurchase Trading
December 02, 2016 at 01:28 am EST
Share
Press Release
Hiromi Miyata, President and CEO Hiromi Miyata, President and CEO (Stock Code: 9987)
November 9, 2016
Securities Traded: First Sections of the Tokyo and Nagoya Stock Exchanges and the Sapporo Securities Exchange Contact: Director and Senior Executive Officer; Senior General Manager, Corporate Planning Headquarters Shigeru Asano
Tel.: +81-52-961-2331
Notice Regarding Result of Acquisition of Treasury Shares by Own Share Repurchase Trading (ToSTNeT-3) and Completion of Treasury Share Acquisition
Suzuken Co., Ltd. (hereinafter "the Company") announced today that it conducted purchasing for the acquisition of treasury shares announced yesterday (November 8, 2016). The Company also announced that this has completed the acquisition of treasury shares in accordance with a resolution adopted by a meeting of the Board of Directors on November 4, 2016.
Reason for Acquisition of Treasury Shares
To execute agile capital policies in response to changes in the economic environment.
Acquisition Details
Type of Shares Acquired Shares of common stock
Number of Shares Acquired 3,144,100 shares
Acquisition Price ¥3,125 per share
Total Amount of Acquisition Price ¥9,825,312,500
Acquisition Date November 9, 2016
Method of Acquisition Acquisition through Tokyo Stock Exchange Inc.'s own share repurchase
trading (ToSTNeT-3)
(Reference) Details of Resolution to Acquire Treasury Shares (Announced on November 4, 2016)
Type of Shares to Be Acquired Shares of common stock
Number of Shares to Be Acquired 3,300,000 shares (upper limit) (Ratio of total number of issued shares (excluding treasury shares) 3.31%)
Total Amount of the Acquisition Price of the Shares ¥12.0 billion (upper limit)
Suzuken Co. Ltd. published this content on 09 November 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 02 December 2016 06:28:01 UTC.
Original documenthttp://v4.eir-parts.net/v4Contents/View.aspx?template=announcement&sid=33428&code=9987
Public permalinkhttp://www.publicnow.com/view/72059CF88A624E26F11322A7E0A1A9987EDFD34E
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.